Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11309274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Role(s) for Integrins in Human Melanoma Invasion

  2004cited by this paper
• Drosophila in cancer research. An expanding role.

  2000cited by this paper
• Molecular classification of cutaneous malignant melanoma by gene expression profiling

  2000cited by this paper
• Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation

  2000cited by this paper
• Up‐regulation of ephrin‐a1 during melanoma progression

  1999cited by this paper
• E-cadherin regulates the function of the EphA2 receptor tyrosine kinase.

  1999cited by this paper
• Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?

  1999cited by this paper
• Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

  1999influential reference
• Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors.

  1998cited by this paper
• Vascular density does not predict future metastatic disease in clinical stage 1 non‐seminomatous germ cell tumours of the testis

  1998cited by this paper
• Phosphoinositide 3-Kinase Induces Scattering and Tubulogenesis in Epithelial Cells through a Novel Pathway*

  1998cited by this paper
• The Eph family of receptors.

  1997cited by this paper
• Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?

  1997cited by this paper
• Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function.

  1997cited by this paper
• Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

  1997cited by this paper
• Clinical applications of research on angiogenesis

  1996cited by this paper
• cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases.

  1995cited by this paper
• Characterization of a Novel Src-like Adapter Protein That Associates with the Eck Receptor Tyrosine Kinase (*)

  1995cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.

  1995cited by this paper
• Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis.

  1995cited by this paper
• Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis

  1995cited by this paper
• Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase.

  1995cited by this paper
• Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.

  1995cited by this paper
• B61 is a ligand for the ECK receptor protein-tyrosine kinase

  1994cited by this paper
• Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity.

  1994influential reference
• Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas.

  1994cited by this paper
• Novel and known protein tyrosine kinases and their abnormal expression in human melanoma.

  1993cited by this paper
• Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly

  1992cited by this paper
• cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases

  1990cited by this paper

• Targeting autophagy in dysfunctional tumor vasculature

  2025cites this paper
• Tyrosine phosphorylation and the inhibitory C-terminal SAM domain moderately affect transient interactions in a EphA2 cytoplasmic fragment in solution: A combined experimental and molecular modeling study

  2025cites this paper
• Endothelial cell in tumor angiogenesis: Origins, mechanisms, and therapeutic implication

  2025cites this paper
• Targeting PAK1 or PAK4 Uncovers Different Mechanisms of Vascular Reprogramming in Pancreatic Cancer

  2025cites this paper
• Mechanisms of Tumor Cell-Mediated Vasculogenic Mimicry in Cancer Invasion and Metastasis: A Systematic Review.

  2025cites this paper
• Vasculogenic mimicry in human cancers associated with chronic high-risk human papillomavirus infection.

  2025cites this paper
• Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018–present)

  2024influential citation
• Tumor-derived Immunoglobulin-like transcript 4 promotes postoperative relapse via inducing vasculogenic mimicry through MAPK/ERK signaling in hepatocellular carcinoma.

  2024cites this paper
• Characteristics of vasculogenic mimicry and tumour to endothelial transdifferentiation in human glioblastoma: a systematic review

  2023influential citation
• An Overview of Angiogenesis in Bladder Cancer

  2023cites this paper
• Neo-vascularization-based therapeutic perspectives in advanced ovarian cancer.

  2023cites this paper
• VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation

  2023cites this paper
• EphA2 on urinary extracellular vesicles as a novel biomarker for bladder cancer diagnosis and its effect on the invasiveness of bladder cancer

  2022cites this paper
• PARP inhibition promotes endothelial‐like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry

  2022cites this paper
• Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2

  2022cites this paper
• ErbB4‐mediated regulation of vasculogenic mimicry capability in breast cancer cells

  2021cites this paper
• The role of hypoxia in endometrial cancer.

  2021cites this paper
• A neurovascular-unit-on-a-chip for the evaluation of the restorative potential of stem cell therapies for ischaemic stroke

  2021cites this paper
• Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates

  2021cites this paper
• Cancer Stem Cells and Neovascularization

  2021cites this paper
• Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments

  2021cites this paper
• Oncogenic Functions and Therapeutic Targeting of EphA2 in Cancer

  2021cites this paper
• COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis

  2021cites this paper
• The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers

  2021cites this paper
• Artesunate Suppresses Choroidal Melanoma Vasculogenic Mimicry Formation and Angiogenesis via the Wnt/CaMKII Signaling Axis

  2021cites this paper
• Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - Interest in making it a therapeutic target.

  2021cites this paper
• The Expression Profile and Prognostic Values of EPHA Family Members in Breast Cancer

  2021cites this paper
• Esophageal carcinoma cell-excreted exosomal uc.189 promotes lymphatic metastasis

  2021cites this paper
• Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer.

  2021cites this paper
• Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers

  2021cites this paper
• Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model

  2020cites this paper
• Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors

  2020cites this paper
• Hemovasculogenic origin of blood vessels in the developing mouse brain

  2020cites this paper
• Vascular mimicry: Triggers, molecular interactions and in vivo models.

  2020cites this paper
• 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ) inhibits cancer cell metastasis behavior of TNBC via suppressing EMT and VEGF.

  2020cites this paper
• Vasculogenic mimicry

  2020cites this paper
• The Role of Nodal and Cripto-1 in Human Oral Squamous Cell Carcinoma.

  2020cites this paper
• Eph/ephrin family proteins and therapeutic resistance

  2020cites this paper
• A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway

  2020cites this paper
• Function of BMP4 in the Formation of Vasculogenic Mimicry in Hepatocellular Carcinoma

  2020cites this paper
• Elevated Expression of EPHA2 Is Associated With Poor Prognosis After Radical Prostatectomy in Prostate Cancer

  2019cites this paper
• Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.

  2019cites this paper
• Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity

  2019cites this paper
• Vasculogenic Mimicry and Its Role in Cancer

  2019cites this paper
• Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry

  2019cites this paper
• Fact or Fiction, It Is Time for a Verdict on Vasculogenic Mimicry?

  2019cites this paper
• Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma

  2019cites this paper
• Serum promotes vasculogenic mimicry through the EphA2/VE‐cadherin/AKT pathway in PC‐3 human prostate cancer cells

  2019cites this paper
• HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells

  2019cites this paper
• Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells

  2019cites this paper
• Limited importance of EphrinA1–ligand, Src kinase, and focal adhesion kinase in EphA2-mediated regulation of metastasis in Mel-Juso and A375 human melanoma cells

  2019cites this paper
• Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma.

  2019cites this paper
• S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer

  2019cites this paper
• Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?

  2019cites this paper
• Endothelial cell‐specific redox gene modulation inhibits angiogenesis but promotes B16F0 tumor growth in mice

  2019cites this paper
• EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients.

  2018cites this paper
• Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in Cell.

  2018cites this paper
• Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate

  2018cites this paper
• Hsp90β promotes aggressive vasculogenic mimicry via epithelial–mesenchymal transition in hepatocellular carcinoma

  2018cites this paper
• Migration‐inducing gene‐7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry

  2018cites this paper
• EPHA 2 sequence variants are associated with susceptibility to Kaposi ’ s sarcoma-associated herpesvirus infection and Kaposi ’ s sarcoma prevalence in HIV-infected patients

  2018cites this paper
• Cooperative multi-targeting of signaling networks by angiomiR-204 inhibits vasculogenic mimicry in breast cancer cells.

  2018cites this paper
• angiogenesis and vasculogenic mimicry are inhibited by 8-Br-caMP through activation of the caMP/PKa pathway in colorectal cancer

  2018cites this paper
• Angiogenesis and vasculogenic mimicry are inhibited by 8-Br-cAMP through activation of the cAMP/PKA pathway in colorectal cancer

  2018cites this paper
• angiogenesis and vasculogenic mimicry are inhibited by 8-Br-caMP through activation of the caMP/PKa pathway in colorectal cancer

  2018cites this paper
• Tyrosine kinase activity of EphA2 promotes its S897 phosphorylation and glioblastoma cell proliferation.

  2018cites this paper
• Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry

  2017cites this paper
• Structural and functional identification of vasculogenic mimicry in vitro

  2017cites this paper
• Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin

  2017cites this paper
• Morphofunctional basis of the different types of angiogenesis and formation of postnatal angiogenesis-related secondary structures.

  2017cites this paper
• The impact of EPHA 2 polymorphism on KSHV infectivity and KS prevalence among HIV / AIDS patients in South Africa

  2017cites this paper
• Clinical studies and future prospects

  2017cites this paper
• Vasculogenic mimicry and tumor metastasis.

  2016cites this paper
• Tumor cell vascular mimicry: Novel targeting opportunity in melanoma.

  2016cites this paper
• EphA2 is a functional receptor for the growth factor progranulin

  2016cites this paper
• Natural Products with Antiangiogenic and Antivasculogenic Mimicry Activity.

  2016cites this paper
• Liver Cancer: Stem and Progenitor Cells

  2016cites this paper
• Analysis of caveolin‐1 and phosphoinositol‐3 kinase expression in primary uveal melanomas

  2016cites this paper
• Expression von EphA2 in metastasierten und nicht metastasierten primären uvealen Melanomen

  2016cites this paper
• Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K

  2016cites this paper
• Association between Tumor Vasculogenic Mimicry and the Poor Prognosis of Gastric Cancer in China: An Updated Systematic Review and Meta-Analysis

  2016cites this paper
• Introduction Vasculogenic mimicry and tumor metastasis

  2016cites this paper
• Expression von EphA 2 in metastasierten und nicht metastasierten primären uvealen Melanomen Expression of EphA 2 in Metastatic and Non-Metastatic Primary Uveal Melanoma

  2016cites this paper
• Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP.

  2015cites this paper
• Molecular mechanism of vasculogenic mimicry in tumors

  2015cites this paper
• Vasculogenic mimicry is a major feature and novel predictor of poor prognosis in patients with orbital rhabdomyosarcoma.

  2015cites this paper
• Vasculogenic mimicry: lessons from melanocytic tumors.

  2015cites this paper
• Dual effects of collagenase-3 on melanoma: metastasis promotion and disruption of vasculogenic mimicry

  2015cites this paper
• Targeting the EPHA2 receptor tyrosine kinase in KRAS and EGFR mutant lung cancer

  2015cites this paper
• Advanced research on vasculogenic mimicry in cancer

  2015cites this paper
• Preclinical and clinical development of siRNA-based therapeutics.

  2015cites this paper
• A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas

  2015cites this paper
• Targeting Epirubicin Plus Quinacrine Liposomes Modified with DSPE-PEG2000-C(RGDfK) Conjugate for Eliminating Invasive Breast Cancer.

  2015cites this paper
• Vasculogenic Mimicry: An Alternative Mode of Tumor Angiogenesis

  2015cites this paper
• Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo

  2015cites this paper
• Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.

  2014influential citation
• Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics

  2014cites this paper
• Inhibition of Tumor Vasculogenic Mimicry and Prolongation of Host Survival in Highly Aggressive Gallbladder Cancers by Norcantharidin via Blocking the Ephrin Type a Receptor 2/Focal Adhesion Kinase/Paxillin Signaling Pathway

  2014cites this paper
• Advances in investigations on the mechanism of cancer multidrug resistance and the liposomes-based treatment strategy

  2014cites this paper
• Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches

  2014cites this paper